Evidence map›Paper›PMID 35893958›Full record

ArticlePolymers2022

Molecular Docking and Efficacy of

Reham Yahya, Aisha M H Al-Rajhi, Saleh Zaid Alzaid, Mohamed A Al Abboud, Mohammed S Almuhayawi, Soad K Al Jaouni, Samy Selim, Khatib Sayeed Ismail, Tarek M Abdelghany

Abstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Natural Bioactive Compounds fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Impacts ofToxicology research · 2025
    Article
  18. Chitosan nanoparticles loaded withOpen veterinary journal · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Reham YahyaBasic Sciences Department, College of Science and Health Professions, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-7740-2433
Aisha M H Al-RajhiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Saleh Zaid AlzaidAssistant Agency for Preventive Health, Ministry of Health, Riyadh 11671, Saudi Arabia.
Mohamed A Al AbboudBiology Department Faculty of Science, Jazan University, Jazan 45142, Saudi Arabia.
Mohammed S AlmuhayawiDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Soad K Al JaouniDepartment of Hematology/Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72341, Saudi Arabia.ORCID 0000-0003-4025-8586
Khatib Sayeed IsmailBiology Department Faculty of Science, Jazan University, Jazan 45142, Saudi Arabia.
Tarek M AbdelghanyBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 71524, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medicinal administration of

Indexed as

Aloe verachitosan nanoparticlesevaluationHelicobacter pylorin vitrotherapeutic effects

Identifiers

PMID35893958
PMCPMC9330094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.